Bio::Neos bioneos.com


Public lists: Pharma Startups (4732)

Bio::Neos aims to provide bioinformatics software tools to aid commercial and academic research groups in efficiently and effectively performing genomics-enabled research. The company specialize in mutation identification research and custom software solutions specifically developed to meet the needs of research groups of any size.

Bio::Neos aims to provide bioinformatics software tools to aid commercial and academic research groups in efficiently and effectively performing genomics-enabled research. The company specialize in mutation identification research and custom software...Show all

Company (Alive / Active)

Phone:

Fax:

Suite 1 Technology Innovation Center
University of Iowa
Iowa City, 52242
Iowa, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Bio::Neos $0M Nov 30, 2018
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Bio::Neos Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Invitrogen

Carlsbad, California, United States
MergedInvitrogen is a brand under the Thermo Fisher Scientific corporation. The company's product line includes subbrands of biotechnology products such as machines and consumables for stem cell and cell therapy.Login to see details

Transgenomic

Omaha, Nebraska, United States
Alive / ActiveTransgenomic (NASDAQ:TBIO) is a global biotechnology company that advances personalized medicine in oncology and inherited diseases via its products and services for automated high-sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery, and laboratory testing services to the academic and medical research, clinical laboratory, and biopharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Their flagship product is ICE ...Show allLogin to see details
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)